Aromatase and COX-2 expression in human breast cancers

Journal of Steroid Biochemistry and Molecular Biology

Volumn 79, Issue 1-5, 2001, Pages 41-47

  Brodie, A M H ^a   Lu, Q ^a   Long, B J ^a   Fulton, A ^a   Chen, T ^a   Macpherson, N ^b   DeJong, P C ^c   Blankenstein, M A ^c   Nortier, J W R ^c   Slee, P H T J ^c   Van de Ven, J ^c   Van Gorp, J M H H ^c   Elbers, J R J ^c   Schipper, M E I ^c   Blijham, G H ^c   Thijssen, J H ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Aromatase; COX 2; Immunohistochemistry

Indexed keywords

AMINOGLUTETHIMIDE; ANASTROZOLE; AROMATASE; AROMATASE INHIBITOR; ESTROGEN; EXEMESTANE; LETROZOLE; POLYCLONAL ANTIBODY; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TAMOXIFEN; VOROZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BREAST CANCER; CANCER GROWTH; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTROGEN SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; TISSUE SECTION;

ADIPOCYTES; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CYCLOOXYGENASE 2; DINOPROSTONE; ENDOTHELIUM; ENZYME INHIBITORS; EPITHELIAL CELLS; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; NITRILES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STROMAL CELLS; TAMOXIFEN; TRIAZOLES;

ANIMALIA;

EID: 0035714723     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00131-5     Document Type: Conference Paper

References (32)

1. Concentration of sex steroids in adipose tissue after menopause
2. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue
3. Aromatase, 17β hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal breast tissue in post-menopausal women
4. A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumor tissues in post-menopausal women
5. In situ oestrone synthesis in normal breast and breast tumor tissues: Effect of treatment with 4-hydroxyandrostenedione
6. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen dependent processes in reproduction and breast cancer
7. Comprehensive pharmacology and clinical efficacy of aromatase inhibitors
8. Intratumoral aromatase as a prognostic factor in human breast carcinoma
9. Relationship between tumor aromatase activity, tumor characteristics and response to therapy
10. Prognostic value of breast cancer aromatase
11. Expression of aromatase protein and messenger RNA in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers
12. 2 via cAMP, leading to activation of promoter II of the CYP19 (aromatase) gene
13. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells
14. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in post-menopausal women with advanced breast cancer: Results of overview analysis of two phase III trials
15. Anastrozole versus megestrol acetate in the treatment of post-menopausal women with advanced breast carcinoma
16. Letrozole, a new oral aromatase inhibitor for advanced breast cancer: Double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate
17. Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5 mg daily, daily 0.5 mg daily and aminoglutethimide in post-menopausal women with advanced breast cancer
18. Exemestane is superior to megestrol acetate after tamoxifen failure in post-menopausal women with advanced breast cancer: Results of a phase III randomized, double-blind trial
19. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in post-menopausal women: Results of a North American multicenter randomized trial
20. Femara 7 (letrozole) showed significant improvement in efficacy over tamoxifen as first-line treatment in post-menopausal women with advanced breast cancer
21. A new nude mouse model for post-menopausal breast cancer using MCF-7 cells transfected with the human aromatase gene
22. The effect of aromatase inhibitors and antiestrogens in the nude mouse model
23. Evaluation of the cancer patient and the response to treatment
24. Preparation and characterization of polyclonal and monoclonal antibodies against human aromatase cytochrome P-450 and their use in its purification
25. Aromatase inhibitors and their antitumor effects in model systems
26. Aromatase activity in cancer cells derived from a patient with recurrent breast cancer
27. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens
28. The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer
29. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells
30. Estrogen regulates vascular endothelial growth/permeability factor expression in DMBA induced rat mammary tumors